Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-24 @ 3:28 PM
NCT ID:
NCT06663592
Eligibility Criteria:
Inclusion Criteria:
1. Current continuous or intermittent pain that has persisted for more than 3 months.
2. Motor, reflex, and/ or sensory changes in the upper limb.
3. Diminished deep tendon reflexes in the affected arm.
4. Paresthesia or numbness along the course of the nerve.
5. A positive Upper Limb Neural Tension 1 (ULNT) test for the median nerve, Spurlings test, compression test, cervical distraction test, less than 60° cervical rotation towards the symptomatic side, and Valsalva maneuver.
6. Unilateral affection in the upper limb.
Exclusion Criteria:
1. History of surgical procedures for pathologies giving rise to neck pain or CTS.
2. Clinical signs or symptoms of medical red flags; (infection, cancer, and cardiac involvement).
3. Patients with neck pain for signs and symptoms of serious pathology, upper cervical ligamentous insufficiency, unexplained cranial nerve dysfunction, and fracture.
4. Any systematic disease such as rheumatism and tuberculosis, cervical myelopathy, or multiple sclerosis.
5. Systemic disease is known to cause generalized peripheral neuropathy as diabetes mellitus.
6. Upper Motor neuron disease such as stroke and amyotrophic lateral sclerosis (ALS).
7. Complete loss of sensation along the involved nerve root.
8. Primary report of bilateral radiating arm pain.
9. Inability to tolerate the planned intervention.
10. Pregnant woman.
11. Thoracic outlet syndrome
12. Pronator teres syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
50 Years
Study:
NCT06663592
Study Brief:
Protocol Section:
NCT06663592